Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Nusantara Gemilang Tbk. vs Merck Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 2.31M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 21.9K 24h volume). The key difference: Merck Tbk. is far larger — about 6.2× Citra Nusantara Gemilang Tbk.'s market cap, and Citra Nusantara Gemilang Tbk. is more actively traded (2.31M versus 21.9K). Which is the better fit depends on your goals.
| CGAS | MERK | |
|---|---|---|
Market Cap | 272.81B | 1.7T |
Volume | 2.31M | 21.9K |
Lot | 23.07K | 219 |
Turnover | 352.57M | 83.99M |
Average Price | 152.85 | 3,834.93 |
Value | 352.57M | 83.99M |
Indicative Equilibrium Price | 154 | 3,850 |
Indicative Equilibrium Volume | 94.2K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
